Economics Press Release

New Columbia Business School Research Finds that Local Political Leaders Are Influenced By and Display Demand For Research Relevant to their Policy Choices

New Columbia Business School research is the first to assess the impact of introducing new drugs on both branded and generic drug prices

New Columbia Business School Research Raises Questions About Role of Medical Device Rep-Physician Relationships in Choices for Patient Care

New research from Columbia Business School captures data from before and after implementation of New York’s 2018 PFL law; finds employers – not just employees and families – give policy high marks

In a new study on hospital mortality rates, Columbia Business School’s Merrill Lynch Professor of Workforce Transformation Ann P. Bartel and Associate Professor of Business Carri W. find that increasing heart attack patients’ length of stay by just one day could decrease 30-day mortality rates and save lives

NEW YORK – In recent years, costs for new prescription drugs in the United States have skyrocketed 60%, and elected officials regularly call for measures to bring down prices. But behind the soaring prices for new medicine, patients are demonstrating a stronger commitment to treatment protocol.

Examining commuting patterns and lockdown measures in three major cities, Amit Khandelwal, Columbia Business School’s Jerome A. Chazen Professor of Global Business, argues that policymakers should abandon the blanket shutdown strategies commonly used in the first few months of the pandemic

Columbia Business School Study Finds that Households are Spending Stimulus Checks on Non-Durable Goods and Basic Needs, then Saving the Rest

New research from Columbia Business School’s Assistant Professor of Business Christian Moser and MUTB Professor of International Business Pierre Yared argues that a lack of government transparency behind lockdown extension decisions can wreak avoidable long-term havoc on the economy

Research from Chazen Senior Scholar Jonas Hjort shows political leaders value research findings, even willing to pay to learn results of impact evaluations